Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC, cannabidiol, and their combination for peripheral neuropathic pain
2017-005198-38Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dronabinol and cannabidiol in Peripheral neuropathic pain (4 arms), sponsored by University Hospital Odense. Primary endpoint: Weekly mean average daily pain. Started Jan 2018; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on 2017-005198-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005198-38.